JUST IN: FDA authorizes Omicron booster for kids as young as 5
The FDA’s emergency use authorizations apply to the Moderna and Pfizer bivalent vaccines.
The FDA said the booster shot should be taken "at least two months following completion of primary or booster vaccination."
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
FDA authorizes omicron-targeting COVID-19 booster for younger kidsThe Food and Drug Administration authorized the bivalent COVID-19 booster shot for younger children. Moderna's booster is authorized for children six years and older.
続きを読む »
Covid-19 Boosters Targeting Omicron Authorized for Kids as Young as 5The FDA’s decision broadens a campaign by health officials to bolster protection against the Omicron strains of the coronavirus.
続きを読む »
FDA clears updated COVID boosters for kids as young as 5The FDA has authorized updated COVID-19 boosters for children as young as 5, seeking to expand protection ahead of an expected winter wave.
続きを読む »
FDA authorizes bivalent COVID-19 boosters for children ages 5 to 11Children ages 5 to 11 can now get a COVID booster after the FDA authorized the bivalent dose Wednesday from both Pfizer-BioNTech and Moderna.
続きを読む »
FDA authorizes updated COVID-19 boosters for children as young as 5The updated shots contain half the recipe that targeted the original coronavirus strain and half protection against the dominant BA.4 and BA.5 omicron versions.
続きを読む »